26 marzo 2015
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus. It differs from other Ebola vaccines because as an inactivated whole virus vaccine, it primes the host immune system with the full complement of Ebola viral proteins and genes, potentially conferring greater protection.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/7oiDKvx007M/150326151426.htm
